Close Menu

comparative effectiveness

The Institute for Clinical and Economic Review is seeking public comment on its plan to evaluate the cost-effectiveness of EGFR inhibitors and immunotherapies.

This article has been updated with a comment from one of the researchers regarding which tests will be included in the study.

This article has been updated to clarify information about NIH's Genetic Testing Registry.

The Personalized Medicine Coalition is urging its members to comment on how a draft methodology report from the Patient-Centered Outcomes Research Institute can better address comparative-effectiveness research involving molecularly targeted personalized treatments.

The Patient-Centered Outcomes Research Institute has released the first draft of its methodology report, which aims to improve the design of studies comparing the impact of differe

UBC's CER capabilities could help Sanofi opportunistically apply pharmacogenomic strategies in drug development and commercialize personalized medicines.

The firms will include pharmacogenomics and personalized medicine approaches as part of an alliance to develop drugs that are more effective in real-world settings.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.